1. Home
  2. BWEN vs PRLD Comparison

BWEN vs PRLD Comparison

Compare BWEN & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$3.02

Market Cap

82.8M

Sector

Industrials

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$1.87

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWEN
PRLD
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.8M
69.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BWEN
PRLD
Price
$3.02
$1.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$4.00
AVG Volume (30 Days)
279.6K
491.0K
Earning Date
03-04-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
63.89
N/A
EPS
0.23
N/A
Revenue
$153,877,000.00
$10,500,000.00
Revenue This Year
$11.68
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.07
N/A
Revenue Growth
N/A
250.00
52 Week Low
$1.41
$0.61
52 Week High
$4.15
$4.22

Technical Indicators

Market Signals
Indicator
BWEN
PRLD
Relative Strength Index (RSI) 42.17 42.81
Support Level $2.94 $1.90
Resistance Level $3.40 $2.20
Average True Range (ATR) 0.28 0.25
MACD -0.08 -0.06
Stochastic Oscillator 6.61 9.39

Price Performance

Historical Comparison
BWEN
PRLD

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: